Clinical Trial Update: The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of docetaxel in patients with cancer to characterize dosing and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Hospira, now a wholly owned subsidiary of Pfizer | Conditions: Cancer | Phase 1 | Status: COMPLETED